Karolinska Development AB
Overview
Karolinska Development AB is a Nordic life sciences investment company focused on identifying and investing in breakthrough medical innovations to create and grow companies that advance these assets into commercial products.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BOOST Pharma | Oct 2025 | Convertible Debt | Co-investor |
| BOOST Pharma | May 2024 | VC Round | Co-investor |
| RAPP | May 2023 | VC Round | Co-investor |
| AnaCardio | Sep 2022 | Series A | Co-investor |
| AnaCardio | Feb 2022 | VC Round | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
